Stockreport

Innate Pharma Reports Full Year 2023 Financial Results and Business Update [Yahoo! Finance]

Innate Pharma S.A. - American Depositary Shares  (IPHA) 
PDF Licensing of a fourth NK cell engager ANKET ® by Sanofi, triggering a €15m payment to Innate; ANKET ® partnered assets progressing well with two molecules in clinical t [Read more]